Metraipolis › archive › dc_f361054df293

Next generation approaches in cancer immunotherapy targeting mechanisms beyond PD1 and PDL1 — Europe PMC PMID:41832248

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41832248
DOI
10.1007/s12672-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-04T09:48:16.169Z
SHA-256 of the archived text
950ddce7f3b46d451246e54c45974eb6e81c9fb832410c743b67eae001625096
Stable URL of this page
https://metraipolis.com/documento/dc_f361054df293

How to cite

Next generation approaches in cancer immunotherapy targeting mechanisms beyond PD1 and PDL1 — Europe PMC PMID:41832248 — Europe PMC (en), https://europepmc.org/article/MED/41832248 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f361054df293 (Metraipolis archive dc_f361054df293, sha256 950ddce7f3b46d451246e54c45974eb6e81c9fb832410c743b67eae001625096)
BibTeX
@misc{dcf361054df293,
  title = {Next generation approaches in cancer immunotherapy targeting mechanisms beyond PD1 and PDL1 — Europe PMC PMID:41832248},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41832248},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f361054df293; sha256 950ddce7f3b46d451246e54c45974eb6e81c9fb832410c743b67eae001625096},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41832248. Agents can read the archived copy with the MCP tool read_document.